Our Mission
Improving the care of cancer patients across Canada through collaboration, education, and research.
About Us
CanRIO is a network of Canadian rheumatologists and researchers focused on two key areas:
- Managing new rheumatic conditions that develop during cancer immunotherapy (Rh-irAEs)
- Caring for patients with pre-existing rheumatic disease who need immunotherapy
Main Objectives
Clinical Care
Leaders in optimizing clinical care for patients with rheumatic immune-related adverse events.
Collaborative Research
Prospective cohort, retrospective cohort, and nested clinical trials to advance understanding and treatment.
Knowledge Translation and Education
Reliable, evidence-based education for physicians, trainees, family members, and allied health professionals.
Advocacy
Ensuring timely access to optimal treatment for all patients.
Building Partnerships
Partnering nationally and internationally to advance the field of rheumatology in immuno-oncology.
Research
CanRIO's prospective cohort, established in 2019, tracks patients with Rh-irAEs and those with pre-existing autoimmune disease receiving immunotherapy across 10 Canadian sites. Our retrospective cohort includes cases since 2013 and is ongoing.
Learn more about our cohort data and view our publications.
CanRIO at a Glance
Support CanRIO
Your donation will help fund critical research to help us understand how best to diagnose and treat side effects of immunotherapy in cancer patients.
Donate to Support CanRIODonations processed through Arthritis Research Canada